Back

Ribosome rescue inhibitors clear Neisseria gonorrhoeae in vivo using a new mechanism

Aron, Z. D.; Mehrani, A.; Hoffer, E. D.; Connolly, K. L.; Torhan, M. C.; Alumasa, J. N.; Srinivas, P.; Cabrera, M.; Hosangadi, D.; Barbor, J. S.; Cardinale, S. C.; Kwasny, S. M.; Morin, L. R.; Butler, M. M.; Opperman, T. J.; Bowlin, T. L.; Jerse, A. E.; Stagg, S. M.; Dunham, C. M.; Keiler, K. C.

2020-06-05 microbiology Community evaluation
10.1101/2020.06.04.132530 bioRxiv
Show abstract

The trans-translation pathway for rescuing stalled ribosomes is conserved and essential in bacterial pathogens but has no mammalian homolog, making it an ideal target for new antibiotics. We previously reported the discovery of a family of acylaminooxadiazoles that selectively inhibit trans-translation, resulting in broad-spectrum antibiotic activity. Optimization of the pharmacokinetic and antibiotic properties of the acylaminooxadiazoles produced MBX-4132, which cleared multiple-drug resistant Neisseria gonorrhoeae infection in mice after a single oral dose. Cryo-EM studies of non-stop ribosomes showed that acylaminooxadiazoles bind to a unique site near the peptidyl-transfer center and significantly alter the conformation of ribosomal protein L27, suggesting a novel mechanism for specific inhibition of trans-translation by these molecules. One Sentence SummaryRibosome rescue inhibitors reveal a new conformation of the ribosome and kill drug-resistant Neisseria gonorrhoeae in vivo.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.